WallStreetZenWallStreetZen

NYSE: RCUS
Arcus Biosciences Inc Stock Ownership - Who owns Arcus Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arcus Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Carolyn C. TangGeneral Counsel2026-06-1134,090$2.57
$87.75kBuy
Alexander AzoyChief Accounting Officer2026-06-012,562$25.77
$66.02kSell
Ii Robert C. GoeltzChief Financial Officer2026-05-117,763$25.63
$198.97kSell
Juan C. JaenPresident2026-01-052,053$22.34
$45.86kSell
Juan C. JaenPresident2026-01-05100$23.20
$2.32kSell
Juan C. JaenPresident2026-01-0529,670$21.34
$633.16kSell
Ii Robert C. GoeltzChief Financial Officer2025-12-316,552$23.38
$153.19kSell
Alexander AzoyChief Accounting Officer2025-12-184,343$22.25
$96.61kSell
Richard MarkusChief Medical Officer2025-12-174,494$22.16
$99.59kSell
Jennifer JarrettChief Operating Officer2025-12-179,983$22.16
$221.22kSell

1 of 5

RCUS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RCUS insiders and whales buy or sell their stock.

RCUS Shareholders

What type of owners hold Arcus Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gilead Sciences Inc24.99%31,424,760$747.91MInsider
Gilead Sciences Inc24.99%31,424,760$747.91MInstitution
Blackrock Inc12.11%15,226,475$362.39MInstitution
Terry J. Rosen11.46%14,413,895$343.05MInsider
Wellington Management Group LLP4.84%6,089,516$144.93MInstitution
State Street Corp4.30%5,412,901$128.83MInstitution
Suvretta Capital Management LLC4.00%5,030,993$119.74MInstitution
Vanguard Portfolio Management LLC3.40%4,272,056$101.67MInstitution
Vanguard Capital Management LLC3.07%3,856,725$91.79MInstitution
Woodline Partners LP3.00%3,777,798$89.91MInstitution

1 of 3

RCUS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RCUS67.89%32.11%Net SellingNet Buying
BEAM86.44%13.56%Net SellingNet Selling
DYN84.14%15.86%Net SellingNet Selling
GPCR31.31%10.35%Net Selling
ARQT77.57%22.43%Net SellingNet Selling
View Top Biotech Stocks

Arcus Biosciences Stock Ownership FAQ

Who owns Arcus Biosciences?

Arcus Biosciences (NYSE: RCUS) is owned by 94.68% institutional shareholders, 44.78% Arcus Biosciences insiders, and 0.00% retail investors. Gilead Sciences Inc is the largest individual Arcus Biosciences shareholder, owning 31.42M shares representing 24.99% of the company. Gilead Sciences Inc's Arcus Biosciences shares are currently valued at $747.91M.

If you're new to stock investing, here's how to buy Arcus Biosciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.